Lisinopril Tablets USP recalled over manufacturing violations
- Recall date
- July 29, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distribut…
- Recall number
- D-1346-2015
- FDA classification
- Class II
- Brand / firm
- Wockhardt Usa Inc.
- Sold / distributed
- Nationwide
Why it was recalled
CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 92806 6, NDC 64679-928-06.
Get recall alerts
Free email alert whenever Wockhardt Usa Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wockhardt Usa Inc.